Phreesia Reports Profit Turnaround Amid Financial Strain Among Clients
Phreesia (NYSE:PHR) reported strong second-quarter fiscal 2027 results, with revenue rising to $129.5 million and adjusted EBITDA surging to $32.9 million. The healthcare technology company achieved its fifth consecutive quarter of net income and ninth straight period of positive operating cash flow. Despite these gains, management highlighted growing unpredictability in one core business line due to financial strain among clients. The CFO noted increased variability in forecasting network solutions revenue for the second half of each fiscal year, reflecting broader economic pressures on healthcare providers. While Phreesia has taken steps like moderating subscription pricing and restructuring operations to support client retention, these actions have limited near-term pricing power. Sequential declines were observed in total revenue per client and overall revenue due to seasonal factors. Despite the challenges, Phreesia used its cash flow to retire over $23 million in debt during the quarter. The company also expanded a securitization facility for its financing arm. Market signals remain mixed: hedge fund ownership slightly declined while short interest remains at 5.80% of float.
Tickers: $PHR
Topics: cash flow debt reduction EBITDA healthcare technology revenue growth